Stablepoint Partners, LLC

Position in GSK — GSK plc

CIK 2011237 BRAINTREE, MA

Position in GSK

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$5,751,050

-$256,326 QoQ

Shares Held

109,711

+0.8% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

1.00%

of 13F equity value

Holder Rank

#149

of 1,032 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Stablepoint Partners, LLC holds $55,827,894 across 12 Drug Manufacturers - General names. GSK ranks #4 (10.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	31,144	$11,277,865
2	MRK	Merck & Co., Inc.	67,206	$8,635,971
3	JNJ	Johnson & Johnson	29,950	$7,606,401
4	GSK	GSK plc This page	109,711	$5,751,050
5	ABBV	AbbVie Inc.	21,670	$5,453,038
6	PFE	Pfizer Inc	201,036	$4,840,946
7	LLY	ELI LILLY & Co	3,240	$3,886,153
8	GILD	Gilead Sciences, Inc.	23,047	$2,911,757

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,751,050	109,711	+0.8%	Shares	Sole	2026-07-09
2026-03-31	$6,007,376	108,849	-8.1%	Shares	Sole	2026-04-30
2025-12-31	$5,810,896	118,493	-0.1%	Shares	Sole	2026-01-13
2025-09-30	$5,119,164	118,609	-3.8%	Shares	Sole	2025-11-03
2025-06-30	$4,734,489	123,294	+2.1%	Shares	Sole	2025-08-13
2025-03-31	$4,679,637	120,796	+21.3%	Shares	Sole	2025-04-11
2024-12-31	$3,367,254	99,564	-4.6%	Shares	Sole	2025-01-21
2024-09-30	$4,268,035	104,404	+0.1%	Shares	Sole	2024-10-11
2024-06-30	$4,014,356	104,269	+0.0%	Shares	Sole	2024-08-02
2024-03-31	$4,469,840	104,265	+6.5%	Shares	Sole	2024-04-23
2023-12-31	$3,627,803	97,890	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.